FDA & Government News

Sleep Apnea Device Receives FDA Approval

Randomized trial data support the approval, with sustained improvements in apnea severity observed.

Share

  • 1

    aura6000 System approved by FDA for OSA treatment.

  • 2

    Targets adults with moderate/severe obstructive sleep apnea.

  • 3

    65% improvement in apnea-hypopnea index in clinical trials.

  • 4

    Significant reduction in median events per hour reported.

  • 5

    Next-gen device planned with MRI compatibility for 2027.

Original Source(s)

Sleep Apnea Device Receives FDA Approval

  • by Kathryn Wighton

  • March 19, 2026

Related Content

Flu Vaccine Cut Hospitalizations Despite Drifted H3N2 Strain

Interim CDC estimates found the 2025–2026 vaccine reduced outpatient influenza visits by up to 41% and hospitalizations by up to 41%.

Why Right Atrial Pressure May Matter More Than Circulatory Filling Pressure

Review highlights physiologic roles of circulatory filling pressures while questioning the clinical value of measuring them directly.

Not All COPD Is Smoking-Related

Study compares symptoms, spirometry, and inflammatory markers with smoking-related disease.